Open Access

Effects of pine needle essential oil on melanin synthesis in B16F10 cells and its mechanism

  • Authors:
    • Suyuan Lü
    • Bingqing Shang
    • Guolong Liu
    • Luyan Sun
    • Qiu Wu
    • Yue Geng
  • View Affiliations

  • Published online on: June 6, 2025     https://doi.org/10.3892/br.2025.2011
  • Article Number: 133
  • Copyright: © et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the melanin synthesis effect of pine needle essential oil (PNEO) extracted using microwave‑assisted extraction on α‑MSH‑induced B16F10 melanoma cells and its molecular mechanism of action. Cell Counting Kit‑8 was used to measure the safe concentration of B16F10 cells after 24 and 48 h post‑treatment. Tyrosinase (TYR) activity assay was used to examine intracellular enzyme viability; western blotting (WB) and reverse transcription‑quantitative (RT‑qPCR) assays were utilized to assess the transcription and expression of genes and proteins associated with melanogenesis. Relevant targets in the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway were verified by the addition of target inhibitors or activators. Results showed that PNEO decreased the levels of melanin and the activity of TYR in B16F10 cells. RT‑qPCR and WB results showed that PNEO downregulated the expression of melanogenesis‑related genes and proteins such as microphthalmia‑associated transcription factor, TYR, TYR‑related protein‑1 and melanocortin 1 receptor, and reduced the levels of phosphorylated PKA and phosphorylated cyclic‑AMP response binding protein. These results suggested that the inhibitory effect of PNEO on melanin production may be related to the cAMP/PKA pathway. Verification through the addition of target inhibitors or activators confirmed that PNEO regulates melanin synthesis and TYR activity through the cAMP/PKA signaling pathway.

Introduction

Melanocytes are a type of neural crest-derived cells that migrate to the epidermis during embryonic development (1). Upon differentiation, melanocytes spread throughout the skin and begin their main physiological function, which is the production of melanin. Melanin synthesis is a complex process that occurs within melanosomes, specialized organelles found in melanocytes responsible for pigment production and characterized by dendritic morphology (2,3). Melanin plays a crucial role in protecting the skin from UV damage (4,5). However, abnormal accumulation of melanin can lead to skin issues such as melasma, freckles and age spots (6). Numerous whitening agents on the market work by regulating melanin production to control excessive pigmentation and promote skin whitening.

One of the key regulators of melanin production is microphthalmia-associated transcription factor (MITF), which activates critical melanin synthesis-related genes such as tyrosinase (TYR), TYR-related protein (TRP)-1 and TRP-2. MITF is a common downstream target of numerous signaling pathways. The most typical way to interfere with melanin production is through the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway. When α-melanocyte-stimulating hormone (α-MSH) binds to the melanocortin 1 receptor (MC1R) expressed on melanocytes, it activates adenylyl cyclase (AC), leading to an increase in cAMP levels. cAMP then activates PKA by binding to its regulatory subunits. Phosphorylated (p-) PKA translocates to the nucleus and phosphorylates cAMP response element-binding protein (CREB), which in its phosphorylated form initiates the activation of MITF, stimulating the transcriptional expression of key enzymes related to melanin production such as TYR, TRP-1 and TRP-2(7).

TYR is a key enzyme in melanin production, and most skin whitening agents function by inhibiting TYR activity to suppress melanin production (8). Ingredients including hydroquinone (9,10), corticosteroids (11), ascorbic acid (12,13), kojic acid (14,15) and arbutin (16) have been used as skin whitening agents to prevent or treat excessive skin pigmentation. However, these products have drawbacks such as carcinogenicity, instability and easy degradation (10). Therefore, it is necessary to further explore natural active substances with low toxicity and effective inhibition of melanin deposition.

Plant-derived extracts or compounds were used to inhibit melanin deposition (17-19). Essential oils are extracted from various parts of plants such as leaves, flowers, roots and fruits through methods including steam distillation, cold pressing, or solvent extraction. They are composed of terpenes and other aromatic compounds (20) and possess various physiological activities such as antibacterial, insect-repellent, insecticidal, anti-inflammatory, antioxidant and anti-aging properties (21,22). Research has found that the essential oil of Melaleuca quinquenervia and its active components such as 1,8-cineole, α-terpineol and α-pinene can reduce TYR activity and melanin content, as well as decrease oxidative stress levels (23). Studies by Chou et al (24) have shown that the essential oil of Cinnamomum cassia and its main component cinnamaldehyde exhibit favorable anti-TYR and anti-melanin synthesis activities, along with antioxidant properties. Hsiao et al (25) found that the essential oil of Calocedrus formosana could completely inhibit melanin production at a concentration of 80 µg/ml. Further studies reported that the essential oil of Calocedrus formosana could significantly inhibit the expression of TRP-1, TRP-2 and MITF melanin synthesis regulatory proteins (25). Previous research has indicated that essential oils have great value in the cosmetics industry (26,27). Pinus tabuliformis Carrière, a member of the Pinaceae family, is an important forest product from the Pinus genus, with pine needles being one of the key products that can be harvested year-round due to its fast regeneration rate. Studies have reported that pine needle essential oil (PNEO) possesses various physiological activities such as antioxidant (28), anticancer (29), antibacterial (30), mental health (31) and antiviral properties (32). However, there have been no reports on the effect of PNEO from Pinus tabuliformis Carrière on melanin synthesis.

Based on these previous studies and our preliminary experiment, the experiment was designed as follows: A model of α-MSH-induced B16F10 melanin-overexpressing cells was used to investigate the effect of PNEO on melanin production and its molecular mechanism by using microwave assisted extraction, Gas Chromatography-Mass Spectrometry (GC-MS), reverse transcription-quantitative PCR (RT-qPCR), western blotting (WB) and other modern molecular biology techniques, including DOPA oxidation method, BCA assay kit and Cell Counting Kit-8 (CCK-8). Then the content of melanin and the activity of TYR in the cells, the levels of melanogenesis-related genes and proteins such as MITF, TYR, TRP-1 and MC1R, p-PKA and p-CREB were measured as well. The findings of the present study have important implications for the potential use of the PNEO in the cosmetics field.

Materials and methods

Reagents and equipment

B16F10 mouse melanoma cells were kindly provided by Shandong Freda Biotechnology Co., Ltd. α-Arbutin (α-Ar; CAS no: 84380-01-8, purity ≥99%) and α- α-MSH (CAS no: 171869-93-5, purity ≥97%) were obtained from Shanghai Macklin Biochemical Technology. DMEM high glucose culture medium was obtained from M&C Gene Technology. Trypsin-EDTA digestion solution was obtained from Yisheng Biotechnology. Penicillin-streptomycin solution was obtained from HyClone; Cytiva. Fetal bovine serum (FBS) was obtained from Wuhan Pricella Biotechnology Co., Ltd. The CCK-8 was purchased from Biosharp Life Sciences. L-DOPA (CAS: 59-92-7, purity ≥98%) was sourced from Beijing Solarbio Science & Technology Co., Ltd. H89 (PKA inhibitor), IBMX (cAMP activator) and Forskolin (AC activator) were acquired from Beyotime Institute of Biotechnology. RNA extraction reagent, chloroform substitute, RNA dissolution solution, beta-actin (cat. no. GB11001) and HRB-conjugated Goat Anti-Rabbit IgG H&L secondary antibodies (cat. no. GB23303), primary antibody diluent (cat. no. G3337) were obtained from Wuhan Servicebio Technology Co., Ltd. RIPA buffer (purity ≥98%) was sourced from Beijing Solarbio Science & Technology Co., Ltd.

The GC-MS system 8890-5977B was purchased by Agilent. The LS-C0105 CO2 incubator was purchased by NuAire Lab Equipment (https://www.nuaire.com/). The SW-CJ-2D type ultra-clean workbench was procured by Suzhou Hengda Purification Equipment. The HVE-50 high-pressure steam sterilizer pot was obtained from Xinhua Medical Equipment Co., Ltd. and the CKX53 inverted microscope was purchased from Olympus Corporation.

Sample processing

The PNEO was prepared in the Natural Products Research Center of Shandong Normal University. A total of 20 g of pine needle powder from Pinus tabuliformis Carrière was dissolved in distilled water, and the PNEO was extracted by using microwave-assisted extraction technology and stored at 4˚C (33).

PNEO analysis by GC-MS

GC-MS was used to analyze the constituent of PNEO. The analysis employed an Agilent HP-5MS column (30 mm x 0.25 mm x 0.25 µm). The temperature program of the column was initiated at 60˚C, maintained for 1 min, ramped up at a rate of 8˚C/min to 140˚C and held for 2 min the temperature was increased at 2˚C/min to 240˚C and held for 2 min, followed by a further ramp up at 8˚C/min to 280˚C, where it was held for 5 min. Helium (purity, ≥99.999%) was used as the carrier gas at a flow rate of 1.0 ml/min. The inlet temperature was set at 260˚C, and a split injection mode with a split ratio of 10:1 was employed, with an injection volume of 1 µl.

Mass spectrometry analysis was carried out by using instrument utilized an Electron Impact (EI) ionization mode with a voltage of 70 eV, a source and transfer line temperatures of 280˚C. The detection mode operated in full scan (SCAN) mode, nitrogen (N2) (purity, ≥99.999%) was used as the carrier gas. A solvent delay of 3 min was implemented to optimize the analysis process.

Cell culture and grouping

B16F10 melanoma cells were cultivated in DMEM medium containing 10% FBS. The cells were maintained in a humidified 5% CO2 incubator at 37˚C and were sub-cultured every 2-3 days to maintain logarithmic growth for subsequent experimentation. Experimental groups included: i) A control group; ii) PNEO treatment group (300 nM α-MSH + 12.5, 25, 50, 100, 200, 400, 800 µg/ml PNEO); iii) α-MSH model group (300 nM α-MSH); and iv) a positive control group (300 nM α-MSH + 100 µg/ml α-Ar).

CCK-8 cell viability assessment

The cell viability was determined by using the CCK-8 method. B16F10 cells were seeded in a 96-well plate at a density of 5x104 cells/ml. Following a 24-h incubation period, cells were categorized based on Section 2.2.2 and cultured for an additional 24 or 48 h. A 10% CCK-8 working solution was prepared in DMEM medium, replacing the original medium with 100 µl of the working solution per well. Subsequently, cells were further incubated at 37˚C for 1 h before measuring the optical density (OD) at 450 nm using a microplate reader. Cell viability was calculated as follows: (A1-A)/(A0-A) x100%. A1 represents the OD value of the group treated with drugs, including cells, CCK-8 solution and drug solution; A denotes the OD value of the control group with medium and CCK-8 solution but no cells; and A0 signifies the OD value of the group containing cells, medium and CCK-8 solution.

BCA protein assay kit for protein concentration determination

The protein concentration was determined using the BCA Protein Assay Kit following the manufacturer's protocol.

Assay of melanin content

Melanin content was quantified using the NaOH lysis method. B16F10 cells were seeded in 6-well plates at a density of 1.25x105 cells/ml per well, with 2 ml of cell suspension added to each well and then incubated for 24 h. Subsequently, abandoning the original culture medium, 2 ml of fresh medium was added to each well according to the aforementioned grouping. Following an additional 48-h static incubation, cells were washed twice with PBS, harvested by scraping, and centrifuged at 13,201 x g for 5 min at 4˚C. The resulting supernatant was discarded, and 300 µl of 1 M NaOH solution, containing 10% DMSO, was added to each centrifuge tube. After thorough mixing and incubation at 80˚C to solubilize the melanin, vigorous vortex followed. B16F10 lysate containing melanin was then dispensed into a 96-well plate (100 µl per well, with 3 replicates per group), and the absorbance at 405 nm was measured for each well using a microplate reader to determine the relative melanin content. Relative melanin content was calculated as follows: A1/A0 x 100%. A1 represents the OD value of the experimental group, and A0 represents the OD value of the control group.

Assay of TYR activity

The TYR activity within B16F10 cells was assayed in terms of DOPA oxidase activity. The plating and drug administration processes were carried out as aforementioned. After continuous static culture for 48 h, the cells were washed twice with PBS. Then, 500 µl of 1% RIPA solution was added to each well, and the plate was quickly placed in a -80˚C refrigerator for freezing. After being taken out, it was placed at room temperature to thaw so that the cells were ruptured. This freeze-thaw process was repeated several times. Then the cells were collected and centrifuged at 4˚C, 9,167 x g for 5 min. The supernatant was reserved in an ice bath. In a 96-well plate, 50 µl of the supernatant was added, followed by 50 µl of 1 mM L-DOPA solution. After reacting at 37˚C for 1 h, the absorbance was measured at 492 nm. The TYR activity was preliminarily calculated according to the protein concentration, and then the relative activity was compared. Relative TYR activity was calculated as follows: C1/C0 x 100% (3). C1 represents TYR value of the experimental group, and C0 represents TYR value of the control group.

RT-qPCR detection of melanin biosynthesis-related gene expression

RNA Extraction Solution (cat. no. G3013) was sourced from Wuhan Seavil Biotechnology Co., Ltd. Reverse transcription (RT) kit (cat. no. G3337) was provided by Wuhan Saiwell Biotechnology Co., Ltd. Total RNA from B16F10 cells treated with PNEO at a mass concentration of 50 µg/ml and the positive control group α-Ar for 48 h was subjected to reverse transcription on a regular PCR instrument. The cDNA first-strand product obtained from reverse transcription (temperature protocol: 25˚C for 5 min, then 42˚C for 30 min, final 85˚C for 5 sec) served as the template, with various reaction components sequentially added to the tube for amplification on a fluorescent quantitative PCR instrument. SYBR green (obtained from Wuhan Saiwell Biotechnology Co., Ltd.) was used as fluorophore for qPCR. Thermocycling conditions were as follows: Stage 1, 95˚C, 30 sec pre-denaturing; Stage 2, 95˚C, 15 sec denaturation; 60˚C, 30 sec annealing/elongation; Stage 3, 65-95˚C. The expression levels of the Tyr, Trp-1, Trp-2, Mitf and Mc1r genes were analyzed using the 2-ΔΔCq method. Primer sequences are included in Table I.

Table I

Sequences of primers used for reverse transcription-quantitative PCR.

Table I

Sequences of primers used for reverse transcription-quantitative PCR.

Gene namePrimer sequence (5'-3')
TyrSense: TAACTTACTCAGCCCAGCATCC
 Antisense: ATAGTGGTCCCTCAGGTGTTCC
Trp-1Sense: TTCGTTGGAGCTGTGATTGTTG
 Antisense: AGGAATAATGTTGAAAGGTGGGG
Trp-2Sense: AGAAACAACCCTTCCACAGATGC
 Antisense: AAGCTCCCAGGATTCCAATGAC
MitfSense: GCCCTATGGCTATGCTCACTCTT
 Antisense: TGTTCATACCTGGGCACTCACTC
Mc1rSense: CTCATTGACGTGCTCATCTGTGG
 Antisense: TGCTTGTAGTAGGTGATAAAGAGGGT
CrebSense: TGGCTAACAATGGTACGGATGG
 Antisense: GTGCTGTGCGGATCTGGTATGT
Crtc1Sense: AGAAGATCGCACTGCACAACCA
 Antisense: CCACGCTGCTGCTTCCAAT
PrkacaSense: ATCGTCCTGACCTTTGAGTATCTG
 Antisense: AACCGAAGTCTGTCACCTGAATAT
GAPDHSense: CCTCGTCCCGTAGACAAAATG
 Antisense: TGAGGTCAATGAAGGGGTCGT

[i] Tyr, tyrosinase; Trp, Tyr-related protein; MITF, microphthalmia-associated transcription factor; MC1R, melanocortin 1 receptor; CREB, cyclic-AMP response element-binding protein; CRTC1, CREB-regulated transcription coactivator 1.

Detection of melanin biosynthesis-related protein expression

The protein expression levels associated with melanin biosynthesis in B16F10 cells were assessed through western blot (WB) analysis. B16F10 cells were cultured for 24 h based on distinct groupings, exposed to PNEO at a concentration of 50 µg/ml for 48 h, rinsed twice with PBS, desiccated, harvested, lysed, and the resulting lysates were transferred into 1.5-ml centrifuge tubes containing an appropriate volume of RIPA lysis buffer. Cell lysis was carried out on ice for 30 min to ensure complete cellular disruption. Subsequent steps included centrifugation at 4˚C, 12,000-16,000 x g for 10 min, determination of protein concentration, denaturation, SDS-PAGE electrophoresis (10% acrylamide and 25-30 µg protein loaded per lane), PVDF membrane transfer, incubation at room temperature for 30 min for blocking (5% skim milk), addition of primary antibody, and overnight agitation at 4˚C. The membrane underwent three 5-min washes with TBST (0.1% Tween-20), followed by incubation at room temperature for 30 min with a secondary antibody diluted in TBST at a ratio of 1:5,000. After three additional rapid 5-min washes with TBST, the membrane was exposed, and the original image was preserved for subsequent data analysis. An immunoblot image analysis software based on artificial intelligence learning, launched by Wuhan Servicebio Technology Co., Ltd., was used.

Statistical analysis

Each experiment was replicated three times, and the results are presented as the mean ± standard deviation (X ± SD). Data analysis was conducted using GraphPad Prism 9.0.0 software (Dotmatics), employing one-way analysis of variance for comparisons among multiple groups. P#x003C;0.05 was considered to indicate a statistically significant difference.

Results

Analysis of PNEO by GC-MS

The total ion chromatogram of the PNEO obtained by microwave-assisted extraction is shown in Fig. S1 (33), and a summary of its components and relative peak areas is presented in Table SI. By conducting GC-MS analysis of the PNEO extracted using the microwave-assisted method, a total of 332 substances were identified. Peaks with matching degree exceeding 80% were considered as candidate compounds, and after qualitative comparison by retrieving the NIST spectral library (https://webbook.nist.gov/chemistry/), 103 chemical compounds were identified, accounting for 47.39% of the total composition. The relative percentage content of each component in the PNEO was calculated using area normalization. The results showed that the PNEO mainly contained alcohols (11.01%), hydrocarbons (11.04%), esters (9.3%) and terpenes (2.997%). These included Thunbergol (PubChem CID: 5363523; 3.938%), Verticillol (PubChem CID: 5377475; 3.597%), Hentriacontane (PubChem CID: 12410; 2.189%), α-Terpinyl acetate (PubChem CID: 111037; 1.901%), Methyl dehydroabietate (PubChem CID: 14697; 1.842%), α-cadinene (PubChem CID: 12306048; 1.534%), Isopimara-8 (PubChem CID; 13783133) (14), 15-dien-19-saeure-methylester (PubChem CID: 13710744; 1.517%), Cembrene (PubChem CID: 6430770; 1.139%) and α-Terpinene (PubChem CID: 7462; 0.825%), among others.

Effect of PNEO on B16F10 cell viability

The CCK-8 results are demonstrated in Fig. 1A. Treatment of cells with different concentrations of PNEO for 24 h showed a significant impact on cell viability when the concentration exceeded 400 µg/ml. At concentrations #x003C;400 µg/ml, cell morphology was normal, and the cell viability was >85%, with no significant difference compared with the control group (P>0.05). After 48 h of treatment, cell viability decreased significantly with increasing concentration of PNEO. At concentrations #x003C;50 µg/ml, PNEO did not affect cell viability (P>0.05). However, when the PNEO concentration was 100 µg/ml, the cell viability significantly decreased to 81.89±3.27% (P#x003C;0.01). Subsequently, PNEO concentrations of 12.5, 25 and 50 µg/ml were selected for further experiments.

Effect of PNEO on melanin content in B16F10 cells

After 48 h of intervention with 12.5, 25 and 50 µg/ml of PNEO, the melanin content in B16F10 cells was measured. As can be observed in Fig. 1B, when the cells were stimulated by α-MSH, the relative melanin content was 156.25±1.70%, indicating that the high melanin expression cell model was successfully developed. PNEO dose-dependently inhibited melanin content, with melanin inhibition rates of 24.81±1.31%, 31.63±1.31% and 54.36±0.67% in the low, medium and high dose groups, respectively. At 50 µg/ml, PNEO was able to achieve inhibition effects similar to the α-Ar positive control.

Effect of PNEO on TYR activity in B16F10 cells

The results of TYR activity measurement are demonstrated in Fig. 1C. Compared with the control group, the TYR activity in the α-MSH group was 185.22±1.58% (P#x003C;0.0001), indicating the success of the model. Different mass concentrations of PNEO and the α-Ar positive control group inhibited TYR activity in B16F10 cells, showing significant differences compared with the α-MSH model group. In the α-Ar positive control group, the inhibition rate of TYR in B16F10 cells reached 31.36±17.25%, while PNEO at a mass concentration of 50 µg/ml exhibited the strongest inhibition of TYR activity, with an inhibition rate of 17.77±8.57%. This suggests that PNEO could effectively inhibit TYR activity in α-MSH-induced B16F10 cells.

Effect of PNEO on the expression of melanogenesis-related genes

MITF, TYR, TRP-1 and TRP-2 are important signaling molecules in the process of melanogenesis. Based on the results of melanin content and TYR activity, 50 µg/ml of PNEO achieved the optimal inhibitory effect. Therefore, the concentration of PNEO was set at 50 µg/ml in RT-qPCR and WB detection. The gene expression levels of Tyr, Trp-1, Trp-2, Mitf and Mc1r are revealed in Fig. 2. After treatment with PNEO for 48 h, the expression of Tyr, Trp-1, Mitf and Mc1r genes in B16F10 cells was significantly inhibited compared with the α-MSH model group. However, the expression level of Trp-2, which is related to melanin production, showed no significant impact.

Effect of PNEO on the expression of melanin synthesis-related proteins

Through WB experiments, the effect of PNEO on the proteins MITF, TYR, TRP-1 and TRP-2, as well as the phosphorylation levels of proteins in the cAMP/PKA signaling pathway was examined to elucidate the mechanism of action by which PNEO inhibits melanin production in B16F10 cells (Fig. 3). Treatment of B16F10 cells with 50 µg/ml PNEO for 48 h resulted in decreased expression of TYR, TRP-1, TRP-2, MITF and MC1R proteins.

Verification of the effect of PNEO on the cAMP/PKA signaling pathway

The CREB molecule is one of the phosphorylation substrates of various protein kinases. The expression level of p-CREB in the nucleus can indirectly reflect the activity of PKA in the cytoplasm. CREB-regulated transcription coactivator 1 (CRTC1) is dephosphorylated and enters the nucleus, forming a CREB/CRTC1 heterodimer in the nucleus, which enhances the transcription levels on the MITF-M promoter. To verify whether PNEO acts on the cAMP/PKA signaling pathway, the results are shown in Fig. 4. Treatment with PNEO resulted in decreased expression of Crtc1 and Prkaca. After treatment of B16F10 cells with PNEO for 48 h, the protein levels of p-CREB and p-PKA were significantly inhibited (Fig. 5). It was hypothesized that the cAMP/PKA signaling pathway is involved in the process by which PNEO inhibits melanin production.

To further investigate the molecular mechanism underlying the inhibitory effect of PNEO on melanin production, the effects of the PKA inhibitor H89, the cAMP activator IBMX, and the AC activator Forskolin on the signaling pathways related to melanin production were studied in the context of PNEO-mediated melanin inhibition. The results, as shown in Fig. 6A, demonstrate that the addition of PNEO or the H89 inhibitor significantly reduced melanin content, with a synergistic effect observed between the two, resulting in a melanin content of 88.93±1.07%. In Fig. 6B, the results of cellular TYR activity identified that treatment with α-MSH significantly increased TYR activity, while the addition of PNEO or H89 inhibitors decreased TYR activity to 83.55±1.44% and 77.41±0.24%, respectively. Additionally, treatment with PNEO in combination with IBMX or Forskolin activators resulted in increased melanin content (Fig. 6C) and TYR activity (Fig. 6D), with Forskolin activator showing a more significant promotion effect, reaching a TYR activity of 235.18±4.50%. In the groups treated with α-MSH, IBMX, or Forskolin activators in combination with PNEO, both melanin content and TYR activity decreased. These findings validate that PNEO regulates melanin production through the cAMP/PKA signaling pathway.

Discussion

The present study utilized microwave-assisted extraction to extract essential oil from Pinus tabulatus pine needles. Microwave energy generates heat that causes plant cell wall rupture, facilitating rapid dissolution of the extract (34), thereby reducing extraction time compared with traditional steam distillation and offering advantages such as energy savings and reduced production costs (35). Properly reducing the extraction time with microwave-assisted extraction lowers the likelihood of thermal degradation of the extract (36). Additionally, research indicates that plant essential oils extracted using microwave assistance exhibit strong antioxidant capabilities and have a longer shelf life (37,38). In the present study, the effects of microwave-assisted extraction of PNEO on the viability of B16F10 cells were initially tested. The results demonstrated that PNEO had no significant toxic effects on cells at concentrations of 12.5-50 µg/ml. Using α-Ar as a positive control group, the impact of PNEO on melanin content and TYR activity within B16F10 cells was evaluated. The findings revealed that different concentrations of PNEO exhibited significant inhibitory effects on melanin content and TYR activity within the cells. At a concentration of 50 µg/ml, PNEO achieved a similar inhibitory effect on melanin content as α-Ar and significantly suppressed TYR activity. Studies have reported that inhibiting TYR activity is an effective approach to inhibiting melanin formation (39). Previous studies reported that the anti-melanin activity of plant essential oils was mainly attributed to terpenes such as α-pinene, limonene, β-laurene and β-pinene (23,40,41). Additionally, minor components in the oil demonstrate favorable physiological activity and exhibit superior effects in inhibiting melanin formation (42). This suggests that the whitening potential of PNEO may be attributed to the actions of various terpenes present in the oil.

When the skin is exposed to ultraviolet light, keratinocytes produce α-MSH, which in turn induces the MC1R signaling pathway in melanocytes (43,44). The MC1R signaling pathway is crucial for melanin formation. α-MSH activation of the MC1R pathway leads to activation of the cAMP signaling pathway, which subsequently stimulates AC and cAMP production downstream of α-MSH-induced MC1R activation, activating PKA and CREB protein (45). CREB, when phosphorylated, activates and induces the expression of Mitf, which in turn activates the transcription of melanin synthesis-related genes: Mitf, Trp-1, Trp-2 and Tyr. Additionally, Mitf is essential for the development of melanocytes, melanin formation and long-term cell survival (46). Theasinensin A in tea significantly reduces the mRNA expression of Tyr, Trp-1 and Trp-2. It also inhibits the increase in TYR and MITF protein levels during α-MSH exposure, as well as inhibits the phosphorylation of CREB and PKA, thereby reducing melanin synthesis through the cAMP signaling pathway (47). To elucidate the mechanism by which PNEO inhibits melanin production and to identify the signaling pathways regulated by PNEO during the inhibition of melanin production, treatment with PNEO reduced the expression levels of the genes Tyr, Trp-1, Mitf, Mc1r, Crtc1 and Prkaca in B16F10 cells, which are important genes in the melanin production process. Among them, TRP-1 is a 75-kDa protein synthesized in the endoplasmic reticulum, transported through the Golgi apparatus, and transferred to melanosomes (48). TRP-1 enhances TYR activity by forming a stable complex to increase its enzymatic activity and is also involved in the proliferation and morphology of melanocytes (49). Research has shown that diacetyl-caffeic acid cyclohexyl ester can block the nuclear entry of CRTC1 in melanocytes, inhibit the formation of the CREB/CRTC1 heterodimer, decrease the transcription levels on the MITF-M promoter, thus reducing melanin production. CRTC1 is potentially a therapeutic target for pigmentary disorders including melasma, freckles and senile lentigines (50).

Unlike previous studies, PNEO extraction was found to have no significant impact on the expression of the Trp-2 gene. Various pathways are known to reduce melanin production, with past research indicating that intracellular melanin synthesis is primarily influenced by TYR activity. Inhibition of TYR activity significantly weakens melanin synthesis in melanocytes. The findings of this study suggest that PNEO can reduce the levels of MITF, TYR, TRP-1, TRP-2, and MC1R proteins, as well as decrease the phosphorylation levels of molecules related to the cAMP/PKA signaling pathway. Phosphorylated CREB upregulates MITF levels. Treatment with PNEO decreases the levels of the MC1R receptor, leading to a significant reduction in the levels of downstream PKA and CREB phosphorylation in the cAMP signaling pathway, inhibiting MITF activation and expression. This results in the lowered levels of proteins associated with melanin production (TYR, TRP-1, TRP-2), ultimately suppressing melanin production through the cAMP/PKA/CREB signaling pathway.

Similar research findings have been reported previously. For instance, Seo et al (51) discovered in their study on the anti-melanogenesis effects of Leathesia difformis extracts that an increase in α-MSH levels leads to the binding of the MC1R receptor on melanocyte cell membranes, causing an elevation in cAMP and activation of the downstream signaling molecule PKA. This, in turn, increases Mitf expression via CREB activation. Seaweed extracts were found to downregulate the expression of genes related to melanin synthesis, reducing p-CREB levels, indicating that seaweed extracts may inhibit melanin production through the cAMP/PKA/CREB pathway (51).

The effects of plant extracts on the mechanism of melanin production have been previously investigated. The root extract of Astragalus membranaceus inhibits the downregulation of MITF, mediated by cAMP response, CREB and p38 MAPK kinase. The PKA inhibitor H89 and the p38 inhibitor SB203580 have validated that formononetin inhibits melanin synthesis and TYR activity by regulating the PKA/CREB and p38 MAPK signaling pathways (52).

To verify the effect of PNEO on the targets of melanin production signaling pathways, the present study used PNEO treatment while adding the PKA inhibitor H89. The levels of melanin production and TYR activity were further reduced. When cAMP activator IBMX and AC activator Forskolin were added, the levels of melanin production and TYR activity increased. However, adding PNEO weakened this increasing trend. It was validated that PNEO can regulate melanin production and TYR activity through the cAMP/PKA signaling pathway. The results of the present study provide a certain basis for the utilization of pine needle resources. Subsequently, the authors will analyze the effect of the screened components on melanin production through B16F10 cell experiments and explore the signal pathways involved in their inhibitory effect on melanin production. In future studies, a major chemical component in PNEO will be selected and more in-depth research shall be carried out, which will be helpful for the exploration of the pharmacological mechanism of the essential oil.

In conclusion, the present results indicate that PNEO inhibits melanin production through the cAMP/PKA signaling pathway. Mechanistically, PNEO inhibits Mitf expression in B16F10 cells and downstream enzymes such as TYR, TRP-1 and TRP-2 by modulating PKA and CREB protein phosphorylation to suppress melanin synthesis (Fig. 7). This will have important implications for the potential use of the PNEO in the cosmetics field.

PNEO downregulates the expression of Tyr, Trp-1, Crtc1, Mc1r and Mitf genes, as well as TYR, TRP-1, TRP-2, MC1R and MITF proteins in B16F10 cells. It also diminishes the phosphorylation levels of molecules linked to the cAMP/PKA signaling pathway, thus lowering TYR activity and inhibiting melanin synthesis. PNEO or the H89 inhibitor notably reduces melanin content, whereas IBMX or Forskolin activators sustainably elevate melanin content and TYR activity. However, co-treatment with PNEO decreases melanin content and TYR activity. These results suggest that PNEO inhibits melanogenesis via the cAMP/PKA signaling pathway.

Supplementary Material

Gas chromatography-mass spectrometry total ion current diagram of pine needle essential oil extracted by microwave-assisted extraction.
GC-MS analysis of PNEO extracted by MAE.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

SL conducted investigation and formal analysis, and wrote the original draft. BS and GL validated and curated data. LS conducted software analysis and data visualization. QW developed the methodology, acquired funding and wrote, reviewed and edited the manuscript. YG conceptualized and supervised the study, performed project administration, and wrote, reviewed and edited the manuscript. All authors read and approved the final version of the manuscript. YG and SL confirm the authenticity of all the raw data.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Uong A and Zon LI: Melanocytes in development and cancer. J Cell Physiol. 222:38–41. 2010.PubMed/NCBI View Article : Google Scholar

2 

Cui YZ and Man XY: Biology of melanocytes in mammals. Front Cell Dev Biol. 11(1309557)2023.PubMed/NCBI View Article : Google Scholar

3 

Hou L and Pavan WJ: Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: Do all roads lead to Mitf? Cell Res. 18:1163–1176. 2008.PubMed/NCBI View Article : Google Scholar

4 

Tadokoro R, Shikaya Y and Takahashi Y: Wide coverage of the body surface by melanocyte-mediated skin pigmentation. Dev Biol. 449:83–89. 2019.PubMed/NCBI View Article : Google Scholar

5 

Lin JY and Fisher DE: Melanocyte biology and skin pigmentation. Nature. 445:843–850. 2007.PubMed/NCBI View Article : Google Scholar

6 

Maranduca MA, Branisteanu D, Serban DN, Branisteanu DC, Stoleriu G, Manolache N and Serban IL: Synthesis and physiological implications of melanic pigments. Oncol Lett. 17:4183–4187. 2019.PubMed/NCBI View Article : Google Scholar

7 

D'Mello SA, Finlay GJ, Baguley BC and Askarian-Amiri ME: Signaling pathways in melanogenesis. Int J Mol Sci. 17(1144)2016.PubMed/NCBI View Article : Google Scholar

8 

Kim HD, Choi H, Abekura F, Park JY, Yang WS, Yang SH and Kim CH: Naturally-occurring tyrosinase inhibitors classified by enzyme kinetics and copper chelation. Int J Mol Sci. 24(8226)2023.PubMed/NCBI View Article : Google Scholar

9 

Arndt KA and Fitzpatrick TB: Topical use of hydroquinone as a depigmenting agent. JAMA. 194:965–967. 1965.PubMed/NCBI

10 

Draelos ZD: Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 20:308–313. 2007.PubMed/NCBI View Article : Google Scholar

11 

McKesey J, Tovar-Garza A and Pandya AG: Melasma treatment: An evidence-based review. Am J Clin Dermatol. 21:173–225. 2020.PubMed/NCBI View Article : Google Scholar

12 

Kim HM, Byun KA, Oh S, Yang JY, Park HJ, Chung MS, Son KH and Byun K: A mixture of topical forms of polydeoxyribonucleotide, vitamin C, and niacinamide attenuated skin pigmentation and increased skin elasticity by modulating nuclear factor erythroid 2-like 2. Molecules. 27(1276)2022.PubMed/NCBI View Article : Google Scholar

13 

Park HJ, Byun KA, Oh S, Kim HM, Chung MS, Son KH and Byun K: The combination of niacinamide, vitamin C, and PDRN mitigates melanogenesis by modulating nicotinamide nucleotide transhydrogenase. Molecules. 27(4923)2022.PubMed/NCBI View Article : Google Scholar

14 

Saeedi M, Eslamifar M and Khezri K: Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 110:582–593. 2019.PubMed/NCBI View Article : Google Scholar

15 

Zilles JC, Dos Santos FL, Kulkamp-Guerreiro IC and Contri RV: Biological activities and safety data of kojic acid and its derivatives: A review. Exp Dermatol. 31:1500–1521. 2022.PubMed/NCBI View Article : Google Scholar

16 

Wang W, Gao Y, Wang W, Zhang J, Yin J, Le T, Xue J, Engelhardt UH and Jiang H: Kojic acid showed consistent inhibitory activity on tyrosinase from mushroom and in cultured B16F10 cells compared with arbutins. Antioxidants (Basel). 11(502)2022.PubMed/NCBI View Article : Google Scholar

17 

Bairagi J, Saikia PJ, Boro F and Hazarika A: A review on the ethnopharmacology, phytochemistry and pharmacology of Polygonum hydropiper Linn. J Pharm Pharmacol. 74:619–645. 2022.PubMed/NCBI View Article : Google Scholar

18 

Merecz-Sadowska A, Sitarek P, Stelmach J, Zajdel K, Kucharska E and Zajdel R: Plants as modulators of melanogenesis: Role of extracts, pure compounds and patented compositions in therapy of pigmentation disorders. Int J Mol Sci. 23(14787)2022.PubMed/NCBI View Article : Google Scholar

19 

Merecz-Sadowska A, Sitarek P, Kowalczyk T, Zajdel K, Kucharska E and Zajdel R: The modulation of melanogenesis in B16 cells upon treatment with plant extracts and isolated plant compounds. Molecules. 27(4360)2022.PubMed/NCBI View Article : Google Scholar

20 

Bakkali F, Averbeck S, Averbeck D and Idaomar M: Biological effects of essential oils-a review. Food Chem Toxicol. 46:446–475. 2008.PubMed/NCBI View Article : Google Scholar

21 

Saab AM, Gambari R, Sacchetti G, Guerrini A, Lampronti I, Tacchini M, El Samrani A, Medawar S, Makhlouf H, Tannoury M, et al: Phytochemical and pharmacological properties of essential oils from Cedrus species. Nat Prod Res. 32:1415–1427. 2018.PubMed/NCBI View Article : Google Scholar

22 

Al-Khayri JM, Banadka A, Nandhini M, Nagella P, Al-Mssallem MQ and Alessa FM: Essential oil from Coriandrum sativum: A review on its phytochemistry and biological activity. Molecules. 28(696)2023.PubMed/NCBI View Article : Google Scholar

23 

Chao WW, Su CC, Peng HY and Chou ST: Melaleuca quinquenervia essential oil inhibits α-melanocyte-stimulating hormone-induced melanin production and oxidative stress in B16 melanoma cells. Phytomedicine. 34:191–201. 2017.PubMed/NCBI View Article : Google Scholar

24 

Chou ST, Chang WL, Chang CT, Hsu SL, Lin YC and Shih Y: Cinnamomum cassia essential oil inhibits α-MSH-induced melanin production and oxidative stress in murine B16 melanoma cells. Int J Mol Sci. 14:19186–191201. 2013.PubMed/NCBI View Article : Google Scholar

25 

Hsiao WW, Kumar KJS, Lee HJ, Tsao NW and Wang SY: Anti-Melanogenic activity of Calocedrus formosana wood essential oil and its chemical composition analysis. Plants (Basel). 11(62)2021.PubMed/NCBI View Article : Google Scholar

26 

Ailli A, Handaq N, Touijer H, Gourich AA, Drioiche A, Zibouh K, Eddamsyry B, El Makhoukhi F, Mouradi A, Bin Jardan YA, et al: Phytochemistry and biological activities of essential oils from six aromatic medicinal plants with cosmetic properties. Antibiotics (Basel). 12(721)2023.PubMed/NCBI View Article : Google Scholar

27 

Sharmeen JB, Mahomoodally FM, Zengin G and Maggi F: Essential oils as natural sources of fragrance compounds for cosmetics and cosmeceuticals. Molecules. 26(666)2021.PubMed/NCBI View Article : Google Scholar

28 

Zhang S, Xie H, Huang J, Chen Q, Li X, Chen X, Liang J and Wang L: Ultrasound-assisted extraction of polyphenols from pine needles (Pinus elliottii): Comprehensive insights from RSM optimization, antioxidant activity, UHPLC-Q-exactive orbitrap MS/MS analysis and kinetic model. Ultrason Sonochem. 102(106742)2024.PubMed/NCBI View Article : Google Scholar

29 

Qiu B, Jiang W, Qiu W, Mu W, Qin Y, Zhu Y, Zhang J, Wang Q, Liu D and Qu Z: Pine needle oil induces G2/M arrest of HepG2 cells by activating the ATM pathway. Exp Ther Med. 15:1975–1981. 2018.PubMed/NCBI View Article : Google Scholar

30 

Khoury M, El Beyrouthy M, Ouaini N, Iriti M, Eparvier V and Stien D: Chemical composition and antimicrobial activity of the essential oil of Juniperus excelsa M.Bieb. growing wild in Lebanon. Chem Biodivers. 11:825–830. 2014.PubMed/NCBI View Article : Google Scholar

31 

Lizarraga-Valderrama LR: Effects of essential oils on central nervous system: Focus on mental health. Phytother Res. 35:657–679. 2021.PubMed/NCBI View Article : Google Scholar

32 

Ha TKQ, Lee BW, Nguyen NH, Cho HM, Venkatesan T, Doan TP, Kim E and Oh WK: Antiviral activities of compounds isolated from Pinus densiflora (pine tree) against the influenza A virus. Biomolecules. 10(711)2020.PubMed/NCBI View Article : Google Scholar

33 

Lü SY, Shang BQ, Sun LY, Liu GL, Wu Q and Geng Y: Process optimization and antioxidant activity of pine needle essential oil extracted by microwave-assisted extraction. Sci Technol Food Ind. 46:184–191. 2025.(In Chinese).

34 

Bagade SB and Patil M: Recent advances in microwave assisted extraction of bioactive compounds from complex herbal samples: A review. Crit Rev Anal Chem. 51:138–149. 2021.PubMed/NCBI View Article : Google Scholar

35 

Masota NE, Vogg G, Heller E and Holzgrabe U: Comparison of extraction efficiency and selectivity between low-temperature pressurized microwave-assisted extraction and prolonged maceration. Arch Pharm (Weinheim). 353(e2000147)2020.PubMed/NCBI View Article : Google Scholar

36 

Dahmoune F, Nayak B, Moussi K, Remini H and Madani K: Optimization of microwave-assisted extraction of polyphenols from Myrtus communis L. leaves. Food Chem. 166:585–595. 2015.PubMed/NCBI View Article : Google Scholar

37 

Rahim MA, Ayub H, Sehrish A, Ambreen S, Khan FA, Itrat N, Nazir A, Shoukat A, Shoukat A, Ejaz A, et al: Essential components from plant source oils: A review on extraction, detection, identification, and quantification. Molecules. 28(6881)2023.PubMed/NCBI View Article : Google Scholar

38 

Cardoso-Ugarte GA, Juárez-Becerra GP, Sosa-Morales ME and López-Malo A: Microwave-assisted extraction of essential oils from herbs. J Microw Power Electromagn Energy. 47:63–72. 2013.PubMed/NCBI View Article : Google Scholar

39 

Pillaiyar T, Manickam M and Namasivayam V: Skin whitening agents: Medicinal chemistry perspective of tyrosinase inhibitors. J Enzyme Inhib Med Chem. 32:403–425. 2017.PubMed/NCBI View Article : Google Scholar

40 

Mansour RB, Wasli H, Bourgou S, Khamessi S, Ksouri R, Megdiche-Ksouri W and Cardoso SM: Insights on Juniperus phoenicea essential oil as potential anti-proliferative, anti-tyrosinase, and antioxidant candidate. Molecules. 28(7547)2023.PubMed/NCBI View Article : Google Scholar

41 

Yang J, Lee SY, Jang SK, Kim KJ and Park MJ: Inhibition of melanogenesis by essential oils from the citrus cultivars peels. Int J Mol Sci. 24(4207)2023.PubMed/NCBI View Article : Google Scholar

42 

Jimenez-Lopez C, Carpena M, Lourenço-Lopes C, Gallardo-Gomez M, Lorenzo JM, Barba FJ, Prieto MA and Simal-Gandara J: Bioactive compounds and quality of extra virgin olive oil. Foods. 9(1014)2020.PubMed/NCBI View Article : Google Scholar

43 

Valverde P, Healy E, Jackson I, Rees JL and Thody AJ: Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet. 11:328–330. 1995.PubMed/NCBI View Article : Google Scholar

44 

Zhang C, Chery S, Lazerson A, Altman NH, Jackson R, Holt G, Campos M, Schally AV and Mirsaeidi M: Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model. Sci Rep. 10(7277)2020.PubMed/NCBI View Article : Google Scholar

45 

Ozdeslik RN, Olinski LE, Trieu MM, Oprian DD and Oancea E: Human nonvisual opsin 3 regulates pigmentation of epidermal melanocytes through functional interaction with melanocortin 1 receptor. Proc Natl Acad Sci USA. 116:11508–11517. 2019.PubMed/NCBI View Article : Google Scholar

46 

Cheng MC, Lee TH, Chu YT, Syu LL, Hsu SJ, Cheng CH, Wu J and Lee CK: Melanogenesis inhibitors from the rhizoma of ligusticum sinense in B16-F10 melanoma cells in vitro and zebrafish in vivo. Int J Mol Sci. 19(3994)2018.PubMed/NCBI View Article : Google Scholar

47 

Lim HY, Kim E, Park SH, Hwang KH, Kim D, Jung YJ, Kopalli SR, Hong YD, Sung GH and Cho JY: Antimelanogenesis effects of theasinensin A. Int J Mol Sci. 22(7453)2021.PubMed/NCBI View Article : Google Scholar

48 

Xu Y, Vijayasaradhi S and Houghton AN: The cytoplasmic tail of the mouse brown locus product determines intracellular stability and export from the endoplasmic reticulum. J Invest Dermatol. 110:324–331. 1998.PubMed/NCBI View Article : Google Scholar

49 

Li CY, Gao TW, Wang G, Han ZY, Shen Z, Li TH and Liu YF: The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells. Br J Dermatol. 150:1081–1090. 2004.PubMed/NCBI View Article : Google Scholar

50 

Yun CY, Hong SD, Lee YH, Lee J, Jung DE, Kim GH, Kim SH, Jung JK, Kim KH, Lee H, et al: Nuclear entry of CRTC1 as druggable target of acquired pigmentary disorder. Theranostics. 9:646–660. 2019.PubMed/NCBI View Article : Google Scholar

51 

Seo GY, Ha Y, Park AH, Kwon OW and Kim YJ: Leathesia difformis extract inhibits α-MSH-induced melanogenesis in B16F10 cells via down-regulation of CREB signaling pathway. Int J Mol Sci. 20(536)2019.PubMed/NCBI View Article : Google Scholar

52 

Wu KC, Hseu YC, Shih YC, Sivakumar G, Syu JT, Chen GL, Lu MT and Chu PC: Calycosin, a common dietary isoflavonoid, suppresses melanogenesis through the downregulation of PKA/CREB and p38 MAPK signaling pathways. Int J Mol Sci. 23(1358)2022.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

August-2025
Volume 23 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lü S, Shang B, Liu G, Sun L, Wu Q and Geng Y: Effects of pine needle essential oil on melanin synthesis in B16F10 cells and its mechanism. Biomed Rep 23: 133, 2025.
APA
Lü, S., Shang, B., Liu, G., Sun, L., Wu, Q., & Geng, Y. (2025). Effects of pine needle essential oil on melanin synthesis in B16F10 cells and its mechanism. Biomedical Reports, 23, 133. https://doi.org/10.3892/br.2025.2011
MLA
Lü, S., Shang, B., Liu, G., Sun, L., Wu, Q., Geng, Y."Effects of pine needle essential oil on melanin synthesis in B16F10 cells and its mechanism". Biomedical Reports 23.2 (2025): 133.
Chicago
Lü, S., Shang, B., Liu, G., Sun, L., Wu, Q., Geng, Y."Effects of pine needle essential oil on melanin synthesis in B16F10 cells and its mechanism". Biomedical Reports 23, no. 2 (2025): 133. https://doi.org/10.3892/br.2025.2011